Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

[Therapeutic intervention alternatives in cancer, using attenuated live bacterial vectors: Salmonella enterica as a carrier of heterologous molecules].

Hernández-Luna MA, Luria-Pérez R, Huerta-Yépez S.

Rev Invest Clin. 2013 Jan-Feb;65(1):65-73. Review. Spanish.

PMID:
23745445
2.

Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.

Hwang C, Sanda MG.

Curr Opin Mol Ther. 1999 Aug;1(4):471-9. Review.

PMID:
11713762
3.

Optimization of antitumor immunotherapy mediated by type III secretion system-based live attenuated bacterial vectors.

Wang Y, Gouëllec AL, Chaker H, Asrih H, Polack B, Toussaint B.

J Immunother. 2012 Apr;35(3):223-34. doi: 10.1097/CJI.0b013e31824747e5.

PMID:
22421940
4.

Recombinant viruses as a tool for therapeutic vaccination against human cancers.

Bonnet MC, Tartaglia J, Verdier F, Kourilsky P, Lindberg A, Klein M, Moingeon P.

Immunol Lett. 2000 Sep 15;74(1):11-25. Review.

PMID:
10996623
5.

Rational design of Salmonella-based vaccination strategies.

Spreng S, Dietrich G, Weidinger G.

Methods. 2006 Feb;38(2):133-43.

PMID:
16414270
6.

Host and bacterial factors affecting induction of immune responses to flagellin expressed by attenuated Salmonella vaccine strains.

Sbrogio-Almeida ME, Mosca T, Massis LM, Abrahamsohn IA, Ferreira LC.

Infect Immun. 2004 May;72(5):2546-55.

7.

Efficacy of intracellular activated promoters for generation of Salmonella-based vaccines.

Xu X, Husseiny MI, Goldwich A, Hensel M.

Infect Immun. 2010 Nov;78(11):4828-38. doi: 10.1128/IAI.00298-10. Epub 2010 Aug 23.

8.

Listeria and Salmonella bacterial vectors of tumor-associated antigens for cancer immunotherapy.

Paterson Y, Guirnalda PD, Wood LM.

Semin Immunol. 2010 Jun;22(3):183-9. doi: 10.1016/j.smim.2010.02.002. Epub 2010 Mar 17. Review.

10.

Tumor antigen delivered by Salmonella III secretion protein fused with heat shock protein 70 induces protection and eradication against murine melanoma.

Zhu X, Zhou P, Cai J, Yang G, Liang S, Ren D.

Cancer Sci. 2010 Dec;101(12):2621-8. doi: 10.1111/j.1349-7006.2010.01722.x. Epub 2010 Sep 30.

11.

Vaccine therapy of established tumors in the absence of autoimmunity.

Hodge JW, Grosenbach DW, Aarts WM, Poole DJ, Schlom J.

Clin Cancer Res. 2003 May;9(5):1837-49.

12.

Dendritic cell-based vaccines for the therapy of experimental tumors.

Pajtasz-Piasecka E, Indrová M.

Immunotherapy. 2010 Mar;2(2):257-68. doi: 10.2217/imt.10.7. Review.

PMID:
20635932
14.

Salmonella enterica as a vaccine carrier.

Hegazy WA, Hensel M.

Future Microbiol. 2012 Jan;7(1):111-27. doi: 10.2217/fmb.11.144. Review.

PMID:
22191450
15.

Live-attenuated bacteria as a cancer vaccine vector.

Toussaint B, Chauchet X, Wang Y, Polack B, Le Gouëllec A.

Expert Rev Vaccines. 2013 Oct;12(10):1139-54. doi: 10.1586/14760584.2013.836914. Review.

PMID:
24124876
16.

Cancer immunotherapy based on recombinant Salmonella enterica serovar Typhimurium aroA strains secreting prostate-specific antigen and cholera toxin subunit B.

Fensterle J, Bergmann B, Yone CL, Hotz C, Meyer SR, Spreng S, Goebel W, Rapp UR, Gentschev I.

Cancer Gene Ther. 2008 Feb;15(2):85-93. Epub 2007 Dec 14.

PMID:
18084243
17.

Humoral immune responses inhibit the antitumor activities mediated by Salmonella enterica serovar choleraesuis.

Lee CH, Wu CL, Chen SH, Shiau AL.

J Immunother. 2009 May;32(4):376-88. doi: 10.1097/CJI.0b013e31819d4ebc.

PMID:
19342967
18.

The use of live attenuated bacteria as a delivery system for heterologous antigens.

Garmory HS, Leary SE, Griffin KF, Williamson ED, Brown KA, Titball RW.

J Drug Target. 2003;11(8-10):471-9. Review.

PMID:
15203915
19.

[Characterization of attenuated Salmonella C500 strain with a delta asd mutant and use as an Asd+ balanced-lethal host-vector system].

Zhao Z, Xu Y, Wu B, Cheng X, Li Y, Tang X, Zhang C, Chen H.

Sheng Wu Gong Cheng Xue Bao. 2009 Jan;25(1):29-36. Chinese.

PMID:
19441223
20.

Towards new immunotherapies: targeting recombinant cytokines to the immune system using live attenuated Salmonella.

Rosenkranz CD, Chiara D, Agorio C, Baz A, Pasetti MF, Schreiber F, Dematteis S, Martinez M, Sztein MB, Chabalgoity JA.

Vaccine. 2003 Jan 30;21(7-8):798-801.

PMID:
12531363

Supplemental Content

Support Center